Related Experiment Video
Updated: Feb 21, 2026

04:11
Author Spotlight: Advancements and Challenges in Hepatitis B Virus Detection
Published on: December 15, 2023
4.8K
Distribution of hepatitis B virus infection in Namibia
P Mhata1, T W Rennie, L F Small
1Disease Surveillance Officer, World Health Organization, Windhoek, Namibia. mhatap@who.int.
Summary
Namibia faces a significant public health challenge with hepatitis B virus (HBV) infection, as evidenced by an 11.8% positive rate in 2013. Enhanced screening and surveillance are crucial for effective HBV control strategies.
Area of Science:
- Public Health
- Infectious Diseases
- Virology
Background:
- Namibia declared hepatitis B virus (HBV) infection a public health problem, implementing infant vaccinations in 2009.
- Limited data on HBV infection hinders effective public health interventions.
- WHO estimates suggest 15-60% of African populations may have HBV serological markers.
Purpose of the Study:
- To investigate the distribution of HBV infection in Namibia using 2013 laboratory data.
- To identify high-risk populations and geographical areas for HBV infection.
Main Methods:
- Cross-sectional descriptive study utilizing electronic laboratory data from January-December 2013.
- Data collected from the Namibia Institute of Pathology, Windhoek.
- Testing included pregnant women (antenatal care), HIV/AIDS patients (antiretroviral therapy clinics), and individuals suspected of HBV infection.
Main Results:
- Overall, 11.8% (9,087/77,238) of hepatitis B surface antigen tests were positive.
- Children (0-14 years) accounted for 2.7% of positive results, with equal sex distribution.
- HBV infections were notably higher in females aged 15-39, peaking between 30-34 years. Routine screening was limited to two regions.
Conclusions:
- High HBV positivity rates were observed in pregnant women, HIV/AIDS patients, and suspected cases.
- Recommendations include improving viral hepatitis surveillance and expanding HBV screening for pregnant women and other populations.
- Further population-based studies are needed to determine HBV prevalence and risk factors for national strategy development.

